The overcrowded, unsanitary conditions inside detention facilities along the Rio Grande Valley in southwest Texas, where thousands of immigrants have been held past the maximum 72-hour holding period, are described as “ticking time bomb” in a report released Tuesday by the Department of Homeland Security’s independent watchdog.
Read moreThe Securities and Exchange Commission on Wednesday slapped health tech company Theranos and its founder and CEO Elizabeth Holmes with a complaint accusing them of a $700 million investor-fraud scheme.
Read moreShareholders brought a federal class action against the cancer biotech firm Ignyta for its proposed acquisition by Roche Holding for $27 a share or $1.7 billion.
Read more
Investors claim they were misled when Iovance Biotherapeutics covertly paid a promoter to write articles and send emails pushing its stock until the Securities Exchange Commission stepped in with a cease-and-desist order.
Read moreThe Securities and Exchange Commission claims in court that two bio- and nano-technology research firms bilked at least 77 investors out of total $2.5 million by selling them shares in patents the companies did not possess.
Read moreBlood-testing company Theranos attempted to skirt a federal lawsuit Wednesday by arguing people who claim to have invested in the company aren’t actually investors and have no standing to sue.
Read moreOn the second full day of a whistleblower retaliation trial, the CEO of a biotech company was asked why he typed up and backdated a negative job review for the general counsel he had fired the month before.
Read moreIn a federal class action, shareholders claim directors of Illumina (gene sequencing) issued misleading earnings estimates, and when true earnings were reported the share price sank by 24.8% in one day, from $224.85 to $139.
Read more